Buser Zorica, Brodke Darrel S, Youssef Jim A, Meisel Hans-Joerg, Myhre Sue Lynn, Hashimoto Robin, Park Jong-Beom, Tim Yoon S, Wang Jeffrey C
Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California.
Department of Orthopedics, University of Utah School of Medicine, Salt Lake City, Utah.
J Neurosurg Spine. 2016 Oct;25(4):509-516. doi: 10.3171/2016.1.SPINE151005. Epub 2016 May 27.
The purpose of this review was to compare the efficacy and safety of synthetic bone graft substitutes versus autograft or allograft for the treatment of lumbar and cervical spinal degenerative diseases. Multiple major medical reference databases were searched for studies that evaluated spinal fusion using synthetic bone graft substitutes (either alone or with an autograft or allograft) compared with autograft and allograft. Randomized controlled trials (RCT) and cohort studies with more than 10 patients were included. Radiographic fusion, patient-reported outcomes, and functional outcomes were the primary outcomes of interest. The search yielded 214 citations with 27 studies that met the inclusion criteria. For the patients with lumbar spinal degenerative disease, data from 19 comparative studies were included: 3 RCTs, 12 prospective, and 4 retrospective studies. Hydroxyapatite (HA), HA+collagen, β-tricalcium phosphate (β-TCP), calcium sulfate, or polymethylmethacrylate (PMMA) were used. Overall, there were no differences between the treatment groups in terms of fusion, functional outcomes, or complications, except in 1 study that found higher rates of HA graft absorption. For the patients with cervical degenerative conditions, data from 8 comparative studies were included: 4 RCTs and 4 cohort studies (1 prospective and 3 retrospective studies). Synthetic grafts included HA, β-TCP/HA, PMMA, and biocompatible osteoconductive polymer (BOP). The PMMA and BOP grafts led to lower fusion rates, and PMMA, HA, and BOP had greater risks of graft fragmentation, settling, and instrumentation problems compared with iliac crest bone graft. The overall quality of evidence evaluating the potential use and superiority of the synthetic biological materials for lumbar and cervical fusion in this systematic review was low or insufficient, largely due to the high potential for bias and small sample sizes. Thus, definitive conclusions or recommendations regarding the use of these synthetic materials should be made cautiously and within the context of the limitations of the evidence.
本综述的目的是比较合成骨移植替代物与自体骨移植或异体骨移植在治疗腰椎和颈椎退行性疾病方面的疗效和安全性。检索了多个主要医学参考数据库,以查找评估使用合成骨移植替代物(单独使用或与自体骨移植或异体骨移植联合使用)与自体骨移植和异体骨移植进行脊柱融合的研究。纳入了随机对照试验(RCT)和患者超过10例的队列研究。影像学融合、患者报告的结局和功能结局是主要关注的结局。检索得到214篇引文,其中27项研究符合纳入标准。对于腰椎退行性疾病患者,纳入了19项比较研究的数据:3项RCT、12项前瞻性研究和4项回顾性研究。使用了羟基磷灰石(HA)、HA+胶原蛋白、β-磷酸三钙(β-TCP)、硫酸钙或聚甲基丙烯酸甲酯(PMMA)。总体而言,除了1项研究发现HA移植物吸收率较高外,各治疗组在融合、功能结局或并发症方面没有差异。对于颈椎退行性疾病患者,纳入了8项比较研究的数据:4项RCT和4项队列研究(1项前瞻性研究和3项回顾性研究)。合成移植物包括HA、β-TCP/HA、PMMA和生物相容性骨传导聚合物(BOP)。与髂嵴骨移植相比,PMMA和BOP移植物导致的融合率较低,并且PMMA、HA和BOP发生移植物碎裂、沉降和器械问题的风险更高。在本系统综述中,评估合成生物材料在腰椎和颈椎融合中潜在用途和优越性的证据总体质量较低或不足,这主要是由于存在较高的偏倚可能性和样本量较小。因此,关于使用这些合成材料的明确结论或建议应谨慎得出,并结合证据的局限性。